Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial-Reference-Cited by-同舟云学术

Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial

Published:2024-06 Issue: Volume:141 Page:107516
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Malhotra Atul,Bednarik Josef,Chakladar Sujatro,Dunn Julia P.,Weaver Terri,Grunstein Ron,Fietze Ingo,Redline Susan,Azarbarzin Ali,Sands Scott A.,Schwab Richard J.,Bunck Mathijs C.

Funder

Eli Lilly and Company

Publisher

Elsevier BV

Reference45 articles.

1. Epidemiology of obstructive sleep apnea: a population health perspective;Young;Am. J. Respir. Crit. Care Med.,2002

2. Increased prevalence of sleep-disordered breathing in adults;Peppard;Am. J. Epidemiol.,2013

3. Diagnosis and management of obstructive sleep apnea: a review;Gottlieb;JAMA,2020

4. Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea;Sands;Am. J. Respir. Crit. Care Med.,2014

5. Tongue fat and its relationship to obstructive sleep apnea;Kim;Sleep,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments;Sleep Medicine Reviews;2024-12

2. The Effect of Tirzepatide on Body Composition in People with Overweight and Obesity: A Systematic Review of Randomized, Controlled Studies;Diseases;2024-09-05

3. Charting New Territories in Obesity Management- Traditional Techniques to Tirzepatide;Endocrine Practice;2024-09

4. Are Weight-loss Drugs the Next Treatment for Obstructive Sleep Apnea?;Neurology Today;2024-08-01

5. Obstructive sleep apnea: Overlooked comorbidity in patients with diabetes;World Journal of Diabetes;2024-07-15